医学
胰十二指肠切除术
腺癌
回顾性队列研究
胰腺导管腺癌
胰腺癌
胃肠病学
多元分析
胰头
内科学
外科
胰腺
癌症
作者
Shinichiro Ono,Tomohiko Adachi,Takao Ohtsuka,Ryuichiro Kimura,Kazuyoshi Nishihara,Yusuke Watanabe,Hiroaki Nagano,Yukio Tokumitsu,Atsushi Nanashima,Naoya İmamura,Hideo Baba,Akira Chikamoto,Masafumi Inomata,Teijiro Hirashita,Masayuki Furukawa,Tetsuya Idichi,Hiroyuki Shinchi,Yuichiro Maruyama,Masafumi Nakamura,Susumu Eguchi
出处
期刊:Surgery
[Elsevier BV]
日期:2022-09-16
卷期号:172 (6): 1782-1790
被引量:16
标识
DOI:10.1016/j.surg.2022.08.004
摘要
Patients diagnosed with resectable pancreatic ductal adenocarcinoma often experience early recurrence even after upfront R0 resection. This study aimed to define early recurrence and identify preoperative risk factors for early recurrence after upfront pancreaticoduodenectomy in patients with resectable pancreatic ductal adenocarcinoma of the pancreatic head.This multicenter, retrospective study involved 500 patients who underwent pancreaticoduodenectomy resectable pancreatic ductal adenocarcinoma of the pancreatic head at 10 institutions between 2007 and 2016. Preoperative, intraoperative, and postoperative clinicopathological results were compared between early and non-early recurrence groups. Predictors of early recurrence were determined using statistical analyses.Log-rank tests revealed a significant difference (P < .001) between recurrence within 3 to 6 months and 6 to 9 months. Early recurrence was subsequently defined as recurrence within 6 months. Patients were categorized into early recurrence (n = 104) and non-early recurrence groups (n = 389). The median overall survival of the early and non-early recurrence groups was 8.6 months and 42.6 months (P < .001), respectively. Preoperatively, high carbohydrate antigen 19-9 levels ≥120 U/mL, retroperitoneal invasion, and diabetes mellitus were identified as independent predictive risk factors for early recurrence according to multivariate analysis. Comparing survival rates among patients with 3, 2, 1, or none of these factors, the median overall survival was 17.6 (n = 90), 21.2 (n = 184), 47 (n = 141), and 61.5 (n = 73) months, respectively.The optimal period that defines the early recurrence for resectable pancreatic ductal adenocarcinoma of the pancreatic head is 6 months. Tumor size ≥20 mm, preoperative carbohydrate antigen 19-9 levels ≥120 U/mL, retroperitoneal invasion of the tumor, and the presence of diabetes mellitus are independently associated with early recurrence.
科研通智能强力驱动
Strongly Powered by AbleSci AI